Zeitlin S I, Levitin A, Hakimian O, Becker J A, Macchia R J
Department of Urology, State University of New York Health Science Center at Brooklyn 11203, USA.
Urology. 1996 Sep;48(3):365-7; discussion 367-8. doi: 10.1016/S0090-4295(96)00162-8.
Published reports are devoid of U.S. studies investigating the role of the intravenous urogram (IVU) in adult patients of differing ages with hematuria. To evaluate the efficacy of the IVU in patients less than 55 years old, a retrospective analysis was performed.
The records of all patients (n = 800) undergoing IVU in an inner city hospital from January 1991 through October 1994 were reviewed for age, gender, race, urinalysis data, and cystoscopic and biopsy findings. Age greater than 55 years, recent trauma, and known malignancy were exclusion criteria. Hematuria was the indication for IVU in 128 of 800 patients. Eight (6.2%) of 128 patients had inadequate chart information, leaving a total of 120 evaluable charts.
We stratified the 120 patients by age, degree of hematuria (gross versus microscopic), and gender. The younger group (17 to 40 years old) included 64 patients (53%) and the older group (41 to 55 years old) 56 patients (47%). Gross hematuria was reported in 65 patients (54%), whereas 55 (46%) had microscopic hematuria. Men accounted for 78 patients (65%) and women for 42 (35%). The majority of patients were African-Americans (100 [83%] of 120). Abnormal findings were seen in 17 (14%) of 120 patients. The IVU alone provided no diagnosis of immediate consequence. There was no significant difference in findings between the age groups (P = 0.61), gross and microscopic hematuria (P = 0.28), and men and women (P = 0.59). Contrast reactions occurred in 3 (2.5%) of 120 patients.
In this inner city population younger than 55 years of age, the usefulness of the IVU for the evaluation of hematuria is questionable. It did not establish a diagnosis, modify the subsequent evaluation, or change the therapy in any of our patients.
已发表的报告中缺乏美国针对静脉肾盂造影(IVU)在不同年龄成年血尿患者中作用的研究。为评估IVU在55岁以下患者中的疗效,我们进行了一项回顾性分析。
回顾了1991年1月至1994年10月在一家市中心医院接受IVU检查的所有患者(n = 800)的记录,包括年龄、性别、种族、尿液分析数据以及膀胱镜检查和活检结果。年龄大于55岁、近期有创伤以及已知患有恶性肿瘤为排除标准。800例患者中有128例因血尿接受IVU检查。128例患者中有8例(6.2%)病历信息不完整,最终共有120份可评估病历。
我们根据年龄、血尿程度(肉眼血尿与镜下血尿)和性别对120例患者进行分层。较年轻组(17至40岁)包括64例患者(53%),较年长组(41至55岁)包括56例患者(47%)。65例患者(54%)报告为肉眼血尿,55例(46%)为镜下血尿。男性78例(65%),女性42例(35%)。大多数患者为非裔美国人(120例中的100例[83%])。120例患者中有17例(14%)有异常发现。仅IVU未得出具有直接影响的诊断结果。各年龄组之间(P = 0.61)、肉眼血尿与镜下血尿之间(P = 0.28)以及男性与女性之间(P = 0.59)的检查结果无显著差异。120例患者中有3例(2.5%)发生造影剂反应。
在这个年龄小于55岁的市中心人群中,IVU用于评估血尿的实用性值得怀疑。它未在我们任何一位患者中确立诊断、改变后续评估或改变治疗方案。